Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort in a multinational study: Study design and comparability of cohorts

Alicia W. Gilsenan; Elizabeth B. Andrews; Ryan Michael Ziemiecki; Estel Plana Hortoneda; Joan Fortuny Moya; Miguel Cainzos Achirica; Joan Fortuny Moya; Alicia W. Gilsenan; Miguel Cainzos Achirica; Oscar F Cantero; Robert W V Flynn; Luis Alberto Garcia-Rodriguez; B Kollhorst; Pär Karlsson; Love Linnér; Thomas M MacDonald; Estel Plana Hortoneda; Ana Ruigómez; Tania Schink; Ryan Michael Ziemiecki; Elizabeth B. Andrews

Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort in a multinational study

Study design and comparability of cohorts

Fortuny Moya, J., Gilsenan, A. W., Cainzos Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L. A., Kollhorst, B., Karlsson, P., Linnér, L., MacDonald, T. M., Plana Hortoneda, E., Ruigómez, A., Schink, T., Ziemiecki, R. M., & Andrews, E. B. (2019). Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort in a multinational study: Study design and comparability of cohorts. Pharmacoepidemiology and Drug Safety, 28(Suppl 2), 627. https://doi.org/10.1002/pds.4864

Copy citation